Abstract Search

ea0081ep87 | Adrenal and Cardiovascular Endocrinology | ECE2022

Managing Immune checkpoint inhibitors and adrenal insufficiency in acute setting

Bashir Mahamud , Ramachandran Kirtanya , Volmy Rebecca , Williams Alexanderia , Elonu Akunna , Elekwa Gloria , Fahal Lamis , Rehmani Hassan , Roy Homagni , Mlawa Gideon

The introduction of immune checkpoint inhibitors (ICIs) in clinical management of cancer has had an undeniable impact in management of cancer patients. Currently there are several ICIs are used across Europe including but not limited to, pembrolizumab, atezolizumab, and ipilimumab. Even though their clinical efficacy is reputable, they have the potential of causing serious immunotherapy-related adverse events (irADRs) in several organ systems including endocrine organs. ...

0 shares

ea0081p577 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Covid-19, Dexamethasone and Diabetes(CODED) study: a single centre experience

Meneissy Noha , Waring Scott , Farhana Umme , Kasigwa Sarah , Wang Yishan , Rashid Tasfia , Kim Sohee , Paul Shanta , Hlaing Htet Myat , Darego Sukuta , Siddika Sadia , Nachas Olga , Fahal Lamis , Mahamud Bashir , Mlawa Gideon

Coronavirus (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2, which leads to multi-organ disease. Covid-19 high mortality and morbidity arising from autoimmune destruction of the lungs due to pro-inflammatory cytokines storm, has enabled worldwide collaborative studies aimed at elucidating potential management strategies in order to overcome pandemic. The RECOVERY trial, a multi-centred trial involving 175 United Kingdom based hospitals. The results from thi...

0 shares

Endocrine Abstracts

Managing Immune checkpoint inhibitors and adrenal insufficiency in acute setting

Covid-19, Dexamethasone and Diabetes(CODED) study: a single centre experience

BiosciAbstracts